# Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer

> **NCT02775695** · PHASE2 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 12 (actual)

## Conditions studied

- Resectable Pancreatic Cancer

## Interventions

- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT02775695
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-03
- **Primary completion:** 2018-09-25
- **Final completion:** 2022-05-26
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02775695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02775695, "Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02775695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*